{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:46:29Z","timestamp":1792669589858,"version":"4.5.0"},"reference-count":564,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pneurobio.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T15:02:49Z","timestamp":1491145369000},"page":"18-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington\u2019s disease"],"prefix":"10.1016","volume":"153","author":[{"given":"Shiraz","family":"Tyebji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2017.03.008_bib0005","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1523\/JNEUROSCI.17-17-06707.1997","article-title":"Brain-derived neurotrophic factor enhances long-term potentiation in rat visual cortex","volume":"17","author":"Akaneya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0010","first-page":"195","article-title":"Neurotrophic factors in Huntington\u2019s disease","volume":"146","author":"Alberch","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington\u2019s disease: implications for the functional anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000091921","article-title":"Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6\/2 mouse model of Huntington\u2019s disease","volume":"28","author":"Ali","year":"2006","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington\u2019s disease","volume":"37","author":"Allen","year":"2009","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.cdd.4401662","article-title":"Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways","volume":"12","author":"Almeida","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hipo.10035","article-title":"BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation","volume":"12","author":"Alonso","year":"2002","journal-title":"Hippocampus"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0166-2236(98)01273-9","article-title":"Neurotrophin trafficking by anterograde transport","volume":"21","author":"Altar","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0055","doi-asserted-by":"crossref","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0060","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1152\/jn.01118.2005","article-title":"Altered cortical glutamate receptor function in the R6\/2 model of Huntington\u2019s disease","volume":"95","author":"Andr\u00e9","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1460-9568.2009.07047.x","article-title":"Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids","volume":"31","author":"Andr\u00e9","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andr\u00e9","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsys.2011.00046","article-title":"Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington\u2019s disease","volume":"5","author":"Andr\u00e9","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0080","article-title":"Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington\u2019s disease by the induction of BDNF-dependent synaptic plasticity","author":"Anglada-Huguet","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0085","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","article-title":"Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors","volume":"32","author":"Anzalone","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jnnp.38.7.669","article-title":"Regional distribution of choline acetyltransferase in the human brain: changes in Huntington\u2019s chorea","volume":"38","author":"Aquilonius","year":"1975","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(81)90105-9","article-title":"Stereoselectivity of presynaptic autoreceptors modulating dopamine release","volume":"76","author":"Arbilla","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington\u2019s disease","volume":"68","author":"Ariano","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0105","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.20492","article-title":"Neuronal vulnerability in mouse models of Huntington\u2019s disease: membrane channel protein changes","volume":"80","author":"Ariano","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","article-title":"Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington\u2019s disease: a detailed cellular in situ hybridization study","volume":"72","author":"Augood","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington\u2019s disease","volume":"42","author":"Augood","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0125","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/npp.2008.144","article-title":"Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization","volume":"34","author":"Azdad","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","article-title":"Hypocretin and melanin-concentrating hormone in patients with Huntington disease","volume":"18","author":"Aziz","year":"2008","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.parkreldis.2011.05.012","article-title":"Serotonin and dopamine striatal innervation in Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"17","author":"B\u00e9dard","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.2001.7852","article-title":"Survival signaling and selective neuroprotection through glutamatergic transmission","volume":"174","author":"Bahr","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/319145a0","article-title":"Synapsin I is a microtubule-bundling protein","volume":"319","author":"Baines","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0150","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1523\/JNEUROSCI.22-23-10399.2002","article-title":"Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons","volume":"22","author":"Balkowiec","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0155","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1460-9568.2008.06192.x","article-title":"Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism","volume":"27","author":"Ballion","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0896-6273(04)00265-X","article-title":"Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals","volume":"42","author":"Bamford","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.38.1.84","article-title":"Serum haloperidol concentration and choreiform movements in Huntington\u2019s disease","volume":"38","author":"Barr","year":"1988","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2017.03.008_bib0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2005.04.029","article-title":"Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis","volume":"49","author":"Baskys","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0175","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2007.01.030","article-title":"The interaction between stargazin and PSD-95 regulates AMPA receptor surface trafficking","volume":"53","author":"Bats","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn.2719","article-title":"Characterization of the proteome, diseases and evolution of the human postsynaptic density","volume":"14","author":"Bay\u00e9s","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0166-2236(00)01584-8","article-title":"Energetics in the pathogenesis of neurodegenerative diseases","volume":"23","author":"Beal","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0959-4388(94)90101-5","article-title":"Synaptic plasticity: LTP and LTD","volume":"4","author":"Bear","year":"1994","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0200","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psychres.2010.04.030","article-title":"Earliest functional declines in Huntington disease","volume":"178","author":"Beglinger","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.25750","article-title":"Results of the citalopram to enhance cognition in Huntington disease trial","volume":"29","author":"Beglinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0210","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.molcel.2006.08.017","article-title":"Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers","volume":"23","author":"Behrends","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0215","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0220","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1523\/JNEUROSCI.19-13-05586.1999","article-title":"Spontaneous activity of neostriatal cholinergic interneurons in vitro","volume":"19","author":"Bennett","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0225","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1523\/JNEUROSCI.17-12-04752.1997","article-title":"Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum","volume":"17","author":"Berretta","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0230","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","article-title":"Expression of normal and mutant huntingtin in the developing brain","volume":"16","author":"Bhide","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0235","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/acps.1980.61.s280.63","article-title":"Dopamine and noradrenaline in post-mortem brain in Huntington\u2019s disease and schizophrenic illness","volume":"280","author":"Bird","year":"1980","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0245","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1073\/pnas.94.26.14859","article-title":"The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses","volume":"94","author":"Blank","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","article-title":"Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path","volume":"232","author":"Bliss","year":"1973","journal-title":"J. Physiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0255","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0260","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","article-title":"Decreased striatal monoaminergic terminals in Huntington disease","volume":"54","author":"Bohnen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002826-200209000-00007","article-title":"Olanzapine for Huntington\u2019s disease: an open label study","volume":"25","author":"Bonelli","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004850-200203000-00009","article-title":"High-dose olanzapine in Huntington\u2019s disease","volume":"17","author":"Bonelli","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0275","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pag\u00e8s","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tins.2006.01.002","article-title":"Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?","volume":"29","author":"Bozzi","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","article-title":"BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis","volume":"76","author":"Bramham","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0290","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/01688638408401231","article-title":"Clinical correlates of dementia and disability in Huntington\u2019s disease","volume":"6","author":"Brandt","year":"1984","journal-title":"J. Clin. Neuropsychol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0295","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1389450114666131124140704","article-title":"Current therapeutic advances in patients and experimental models of Huntington\u2019s disease","volume":"15","author":"Brett","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0300","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75(NTR)\/TrkB protein expression in Huntington\u2019s disease: implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0305","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1172\/JCI74809","article-title":"Neurotrophin receptor p75NTR mediates Huntington\u2019s disease-associated synaptic and memory dysfunction","volume":"124","author":"Brito","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BST0380443","article-title":"Synaptopathy: dysfunction of synaptic function?","volume":"38","author":"Brose","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0315","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1046\/j.0953-816x.2001.01541.x","article-title":"An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors","volume":"13","author":"Bruno","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0320","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mds.22376","article-title":"Treatment of the symptoms of Huntington\u2019s disease: preliminary results comparing aripiprazole and tetrabenazine","volume":"24","author":"Brusa","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2015.03.008","article-title":"Cysteine string protein (CSP) and its role in preventing neurodegeneration","volume":"40","author":"Burgoyne","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0330","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.55.9.1249","article-title":"Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum","volume":"55","author":"Calabresi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease","volume":"5","author":"Callahan","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0340","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cne.901650402","article-title":"Nigrothalamic projections in the monkey demonstrated by autoradiographic technics","volume":"165","author":"Carpenter","year":"1976","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0006-8993(97)01566-7","article-title":"5-HT1B receptor binding in degenerative movement disorders","volume":"790","author":"Castro","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0355","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0893-133X(01)00299-8","article-title":"Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors","volume":"26","author":"Centonze","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0365","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0370","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0375","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1046\/j.0953-816x.2001.01783.x","article-title":"Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat","volume":"14","author":"Cepeda","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington\u2019s disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0385","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1460-9568.2008.06038.x","article-title":"Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons","volume":"27","author":"Cepeda","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0390","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1182","article-title":"Rescuing the corticostriatal synaptic disconnection in the R6\/2 mouse model of Huntington\u2019s disease: exercise, adenosine receptors and ampakines","volume":"2","author":"Cepeda","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0395","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington\u2019 s disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0405","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0410","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0415","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington\u2019s disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0420","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington\u2019s disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2007.07.028","article-title":"Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo","volume":"29","author":"Charvin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0430","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archneur.1972.00490090108012","article-title":"Huntington\u2019s chorea: effect of serotonin depletion","volume":"26","author":"Chase","year":"1972","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0435","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0440","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0445","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/35046031","article-title":"Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0450","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cellsig.2006.05.028","article-title":"Norepinephrine induces BDNF and activates the PI-3 K and MAPK cascades in embryonic hippocampal neurons","volume":"19","author":"Chen","year":"2007","journal-title":"Cell Signal."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0455","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1523\/JNEUROSCI.5968-10.2011","article-title":"PSD-95 is required to sustain the molecular organization of the postsynaptic density","volume":"31","author":"Chen","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0460","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","article-title":"Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington\u2019s disease","volume":"45","author":"Chiodi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0465","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1172\/JCI31778","article-title":"Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease","volume":"117","author":"Cho","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0470","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1523\/JNEUROSCI.07-02-00357.1987","article-title":"Glutamate neurotoxicity in cortical cell culture","volume":"7","author":"Choi","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2014.02.004","article-title":"Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington\u2019s disease","volume":"66","author":"Choi","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0480","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0485","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0490","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0495","doi-asserted-by":"crossref","first-page":"A96","DOI":"10.1038\/jcbfm.1991.44","article-title":"The FDG\/PET methodology for early detection of disease onset: a statistical model","volume":"11","author":"Clark","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0500","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrn1556","article-title":"Receptor trafficking and synaptic plasticity","volume":"5","author":"Collingridge","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0505","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","article-title":"Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity","volume":"28","author":"Cowan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0510","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0197-0186(86)90085-9","article-title":"Brain serotonin receptors in Huntington\u2019s disease","volume":"9","author":"Cross","year":"1986","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0515","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0304-3940(86)90397-6","article-title":"Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington\u2019s disease","volume":"67","author":"Cross","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0520","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0525","first-page":"re16","article-title":"Role of distinct NMDA receptor subtypes at central synapses","author":"Cull-Candy","year":"2004","journal-title":"Sci. STKE: Signal Transduct. Knowl. Environ."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0530","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0535","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresbull.2006.10.016","article-title":"Abnormal cortical synaptic plasticity in a mouse model of Huntington\u2019s disease","volume":"72","author":"Cummings","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0540","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0545","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinergic Signall."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0550","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington\u2019s disease mouse models: rescue by D1 dopamine receptor activation","volume":"8","author":"Dall\u00e9rac","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0555","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington\u2019s disease mouse models: rescue by D1 dopamine receptor activation","volume":"8","author":"Dall\u00e9rac","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0560","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00001756-200204160-00034","article-title":"Biphasic developmental changes in Ca2+\/calmodulin-dependent proteins in R6\/2 Huntington\u2019s disease mice","volume":"13","author":"Deckel","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0565","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington\u2019s in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0570","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington\u2019s disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0575","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0580","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0585","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnsys.2014.00198","article-title":"Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington\u2019s disease","volume":"8","author":"Deng","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0590","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5812\/ijhrba.9222","article-title":"The endocannabinoid system: a putative role in neurodegenerative diseases","volume":"2","author":"Di Iorio","year":"2013","journal-title":"Int. J. High Risk Behav. Addict."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0595","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hipo.20294","article-title":"Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors","volume":"17","author":"Di\u00f3genes","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0600","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0605","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington\u2019s disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0610","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(03)02357-6","article-title":"Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain","volume":"970","author":"Dicou","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0615","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0620","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1523\/JNEUROSCI.1623-10.2010","article-title":"Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum","volume":"30","author":"Doig","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0625","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0630","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","article-title":"Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington\u2019s disease","volume":"169","author":"Doria","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0635","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2014.08.021","article-title":"The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington\u2019s disease","volume":"73","author":"Doria","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0640","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington\u2019s disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0645","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0650","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","article-title":"Paroxetine retards disease onset and progression in Huntingtin mutant mice","volume":"55","author":"Duan","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0655","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0660","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.21-15-05546.2001","article-title":"Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane","volume":"21","author":"Dunah","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0665","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archneurpsyc.1927.02210060002001","article-title":"Pathologic changes in Huntington\u2019s chorea","volume":"18","author":"Dunlap","year":"1927","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2009.11.025","article-title":"The dopaminergic stabilizers pridopidine (ACR16) and (\u2212)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties","volume":"628","author":"Dyhring","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0675","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M304615200","article-title":"Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II","volume":"278","author":"Edwardson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0680","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0959-4388(99)80029-4","article-title":"Molecular mechanisms of synaptic plasticity and memory","volume":"9","author":"Elgersma","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0685","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","article-title":"Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin","volume":"6","author":"Engelender","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0690","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.baga.2012.04.029","article-title":"Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington\u2019s disease: interactions between neurons and astrocytes","volume":"2","author":"Estrada-S\u00e1nchez","year":"2012","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0695","first-page":"19","article-title":"Role of cerebral cortex in the neuropathology of Huntington\u2019s disease","volume":"7","author":"Estrada-S\u00e1nchez","year":"2013","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0700","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0705","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington\u2019s disease","volume":"27","author":"Fan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0710","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.expneurol.2011.08.010","article-title":"Reduced striatal acetylcholine efflux in the R6\/2 mouse model of Huntington\u2019s disease: an examination of the role of altered inhibitory and excitatory mechanisms","volume":"232","author":"Farrar","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0715","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/WNF.0b013e318166da60","article-title":"The long-term effect of tetrabenazine in the management of Huntington disease","volume":"31","author":"Fasano","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0720","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0725","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0730","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","article-title":"Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function","volume":"99","author":"Ferr\u00e9","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0735","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/138161208784480108","article-title":"An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors","volume":"14","author":"Ferr\u00e9","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0740","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington\u2019s disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0745","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington\u2019s disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0750","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0755","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2010.01.080","article-title":"Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington\u2019s disease mice","volume":"1323","author":"Ferrante","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0760","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2014.08.013","article-title":"Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington\u2019s disease","volume":"71","author":"Ferrante","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0765","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0770","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/381706a0","article-title":"Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus","volume":"381","author":"Figurov","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0775","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0780","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1152\/jn.00361.2002","article-title":"Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32","volume":"88","author":"Flores-Hern\u00e1ndez","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0785","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1098-2396(199702)25:2<185::AID-SYN9>3.0.CO;2-8","article-title":"Dopamine selects glutamatergic inputs to neostriatal neurons","volume":"25","author":"Flores-Hernandez","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0790","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuropharm.2008.01.011","article-title":"Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine","volume":"54","author":"Fontinha","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0795","first-page":"938530","article-title":"Differential changes in postsynaptic density proteins in postmortem Huntington\u2019s disease and Parkinson\u2019s disease human brains","volume":"2014","author":"Fourie","year":"2014","journal-title":"J. Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0800","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0805","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/NDT.S6430","article-title":"Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease","volume":"6","author":"Frank","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0810","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuint.2014.06.017","article-title":"Dysregulation of system xc- expression induced by mutant huntingtin in a striatal neuronal cell line and in R6\/2 mice","volume":"76","author":"Frederick","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0815","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2008.08.043","article-title":"A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)","volume":"157","author":"Furness","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0820","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.19-01-00109.1999","article-title":"Citron, a Rho-target, interacts with PSD-95\/SAP-90 at glutamatergic synapses in the thalamus","volume":"19","author":"Furuyashiki","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0825","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0830","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0835","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0166-2236(02)02269-5","article-title":"Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance","volume":"25","author":"Gaiarsa","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0840","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","article-title":"Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: evidence for an overactive dopaminergic brain transmission","volume":"58","author":"Garrett","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0845","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0850","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2002-32367","article-title":"Chorea huntington: a rare case with childhood onset","volume":"33","author":"Gencik","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0855","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","article-title":"Postsynaptic endocannabinoid release is critical to long-term depression in the striatum","volume":"5","author":"Gerdeman","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0860","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0865","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1523\/JNEUROSCI.2660-08.2008","article-title":"Dichotomous anatomical properties of adult striatal medium spiny neurons","volume":"28","author":"Gertler","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0870","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0875","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","article-title":"Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington\u2019s disease","volume":"23","author":"Giamp\u00e0","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0880","doi-asserted-by":"crossref","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease","volume":"8","author":"Giamp\u00e0","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0885","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2005.04349.x","article-title":"A similar impairment in CA3 mossy fibre LTP in the R6\/2 mouse model of Huntington\u2019s disease and in the complexin II knockout mouse","volume":"22","author":"Gibson","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0890","first-page":"282","article-title":"Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements","volume":"4","author":"Gim\u00e9nez-Rold\u00e1n","year":"1989","journal-title":"Neurolog\u00eda (Barcelona, Spain)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0895","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.150241097","article-title":"Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes","volume":"97","author":"Gin\u00e9s","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0900","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0905","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain","volume":"23","author":"Gines","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0910","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0915","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant Huntingtin: involvement of phospholipaseC\u03b3 activity and glutamate receptor expression","volume":"158","author":"Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0920","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0925","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease","volume":"20","author":"Giralt","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0930","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0935","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms","volume":"1","author":"Giralt","year":"2012","journal-title":"J. Huntington Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0940","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington\u2019s disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0945","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/hmg\/dds154","article-title":"Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington\u2019s disease mouse model","volume":"21","author":"Gladding","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0950","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12700","article-title":"Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington\u2019s disease mouse model","author":"Gladding","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0955","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington\u2019s disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0960","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0965","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0970","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2006.10.017","article-title":"Depletion of Complexin II does not affect disease progression in a mouse model of Huntington\u2019s disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD","volume":"72","author":"Glynn","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0975","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nlm.2004.07.003","article-title":"Coordination of multiple memory systems","author":"Gold","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0980","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0985","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/mcne.1996.0017","article-title":"Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons","volume":"7","author":"Goodman","year":"1996","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0990","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","article-title":"Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels","volume":"167","author":"Goulart","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib0995","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2015.08.022","article-title":"Synaptopathy \u2013 from biology to therapy","volume":"100","author":"Grant","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1010","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","article-title":"Neurotransmitters and neuromodulators in the basal ganglia","volume":"13","author":"Graybiel","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1126\/science.8430330","article-title":"Synaptic vesicle phosphoproteins and regulation of synaptic function","volume":"259","author":"Greengard","year":"1993","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1013205230142","article-title":"The neurobiology of dopamine signaling","volume":"21","author":"Greengard","year":"2001","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1035","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.25159","article-title":"Striatal neuronal loss correlates with clinical motor impairment in Huntington\u2019s disease","volume":"27","author":"Guo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamaneurol.382","article-title":"A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease","volume":"70","author":"HORIZON Investigators of the Huntington Study Group and European Huntington\u2019s Disease Network","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional specificity of brain atrophy in Huntington\u2019s disease","volume":"154","author":"Halliday","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1050","series-title":"Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model","author":"Hamilton","year":"2016"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1055","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events","volume":"37","author":"Hardingham","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1070","first-page":"117","article-title":"Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington\u2019s disease mice","volume":"26","author":"Harris","year":"2001","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tins.2005.02.004","article-title":"Complementary memory systems: competition, cooperation and compensation","volume":"28","author":"Hartley","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1085","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/jnnp.55.11.1018","article-title":"Reduced regional cerebral blood flow in Huntington\u2019s disease studied by SPECT","volume":"55","author":"Hasselbalch","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1095","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","article-title":"Positron emission tomography in the early diagnosis of Huntington\u2019s disease","volume":"36","author":"Hayden","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1100","series-title":"The Organization of Behavior","author":"Hebb","year":"1949"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00429-011-0340-y","article-title":"A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington\u2019s disease","volume":"217","author":"Heck","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004010050408","article-title":"Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington\u2019s disease","volume":"91","author":"Heinsen","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s004010051037","article-title":"Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease","volume":"97","author":"Heinsen","year":"1999","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.1056","article-title":"Impact of Huntington\u2019s disease on quality of life","volume":"16","author":"Helder","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1130","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","article-title":"Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington\u2019s disease","volume":"11","author":"Hermel","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1140","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathol-012615-044216","article-title":"Dendritic spine pathology in neurodegenerative diseases","author":"Herms","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2007.08.026","article-title":"Presynaptic D1 dopamine receptors facilitate glutamatergic neurotransmission in the rat globus pallidus","volume":"425","author":"Hernandez","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1150","doi-asserted-by":"crossref","first-page":"22569","DOI":"10.1074\/jbc.274.32.22569","article-title":"Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase","volume":"274","author":"Hetman","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nn.2592","article-title":"Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors","volume":"13","author":"Higley","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington\u2019s disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1175","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington\u2019s disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1180","first-page":"2","article-title":"Enhanced GABAergic inputs contribute to functional alterations of cholinergic interneurons in the R6\/2 mouse model of Huntington\u2019s disease","author":"Holley","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/ejn.12045","article-title":"Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington\u2019s disease and mouse models","volume":"37","author":"Horne","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1190","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.45.10.1879","article-title":"Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington\u2019s disease patients","volume":"45","author":"Horton","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction","volume":"72","author":"Huang","year":"2003","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5694\/j.1326-5377.1976.tb140870.x","article-title":"Tetrabenazine in the treatment of Huntington\u2019s chorea","volume":"1","author":"Huang","year":"1976","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0028-3908(98)00050-1","article-title":"Brain-derived neurotrophic factor alters the synaptic modification threshold in visual cortex","author":"Huber","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.25362","article-title":"A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington\u2019s disease","volume":"28","author":"Huntington Study Group HART Investigators","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.2016.8655","article-title":"Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial","volume":"316","author":"Huntington Study Group","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: reliability and consistency","volume":"11","author":"Huntington\u2019s Study Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1230","series-title":"On Chorea. Medical and Surgical Reporter of Philadelphia","first-page":"26","author":"Huntington","year":"1872"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0092-8674(95)90396-8","article-title":"Neuroligin 1: a splice site-specific ligand for beta-neurexins","volume":"81","author":"Ichtchenko","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1240","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.277.5331.1511","article-title":"Binding of neuroligins to PSD-95","volume":"277","author":"Irie","year":"1997","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-328X(00)00043-7","article-title":"Differential activation of MAPK\/ERK and p38\/SAPK in neurones and glia following focal cerebral ischaemia in the rat","volume":"77","author":"Irving","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1250","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1113\/jphysiol.2006.105510","article-title":"Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons","volume":"572","author":"Ivanov","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1255","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/NEN.0b013e3181ee005d","article-title":"Hyperdopaminergic status in experimental Huntington disease","volume":"69","author":"Jahanshahi","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1260","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington\u2019s mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1265","first-page":"80","article-title":"H NMR spectroscopy studies of Huntington\u2019s disease","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1270","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s11064-011-0550-y","article-title":"Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons","volume":"36","author":"Jeon","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-3223(91)90211-4","article-title":"Cerebral structure on MRI, part II: Specific changes in Alzheimer\u2019s and Huntington\u2019s diseases","volume":"29","author":"Jernigan","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1280","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nn.2505","article-title":"Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons","volume":"13","author":"Ji","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nn1870","article-title":"TRPC channels promote cerebellar granule neuron survival","volume":"10","author":"Jia","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1290","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.0953-816x.2001.01751.x","article-title":"Brain-derived neurotrophic factor induces long-lasting potentiation of synaptic transmission in visual cortex in vivo in young rats, but not in the adult","volume":"14","author":"Jiang","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/JMN:25:2:133","article-title":"Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress","volume":"25","author":"Jiang","year":"2005","journal-title":"J. Mol. Neurosci.: MN"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1300","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","article-title":"Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington\u2019s disease","volume":"22","author":"Jiang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2015.02.006","article-title":"Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells","volume":"76","author":"Jiang","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1310","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1315","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00441-006-0273-6","article-title":"NMDA receptor function: subunit composition versus spatial distribution","volume":"326","author":"K\u00f6hr","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","article-title":"HIP1, a human homologue of S cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain","volume":"16","author":"Kalchman","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1325","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1126\/science.7886457","article-title":"Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus","volume":"267","author":"Kang","year":"1995","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1330","first-page":"846","article-title":"Thalamic atrophy in Huntington\u2019s disease co-varies with cognitive performance: a morphometric MRI analysis","volume":"15","author":"Kassubek","year":"2005","journal-title":"Cereb. Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1335","first-page":"17P","article-title":"The site of termination of afferent fibres on the neurones of the caudate nucleus","volume":"210","author":"Kemp","year":"1970","journal-title":"J. Physiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mds.21161","article-title":"Short-term effects of tetrabenazine on chorea associated with Huntington\u2019s disease","volume":"22","author":"Kenney","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1345","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1037\/0735-7044.112.4.1012","article-title":"Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance?","volume":"112","author":"Kesslak","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurol.2009.334","article-title":"A randomized, placebo-controlled trial of latrepirdine in Huntington disease","volume":"67","author":"Kieburtz","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1355","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2004.03.002","article-title":"Functional MRI study of a serial reaction time task in Huntington\u2019s disease","volume":"131","author":"Kim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1365","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/npp.2011.189","article-title":"GABA(A) receptor blockade enhances memory consolidation by increasing hippocampal BDNF levels","volume":"37","author":"Kim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2013.09.015","article-title":"Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells","volume":"62","author":"Kim","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1375","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1380","doi-asserted-by":"crossref","first-page":"12736","DOI":"10.1073\/pnas.0401860101","article-title":"Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking","volume":"101","author":"Kittler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1385","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1126\/science.1057415","article-title":"Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons","volume":"291","author":"Kohara","year":"2001","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1390","first-page":"1737","article-title":"Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95","volume":"269","author":"Kornau","year":"1995","journal-title":"Source: Sci. New Ser."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1395","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.92.19.8856","article-title":"Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor","volume":"92","author":"Korte","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/exnr.1997.6441","article-title":"Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons","volume":"144","author":"Kosinski","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1405","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.tins.2012.09.007","article-title":"The sigma-1 receptor: roles in neuronal plasticity and disease","volume":"35","author":"Kourrich","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1410","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson\u2019s disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1415","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2014.11.022","article-title":"Huntington\u2019s disease: an update of therapeutic strategies","volume":"556","author":"Kumar","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0165-1781(89)90090-5","article-title":"Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington\u2019s disease","volume":"29","author":"Kuwert","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1430","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1435","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1440","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1096\/fj.08-107268","article-title":"Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors","volume":"22","author":"L\u00e9veill\u00e9","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1445","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1523\/JNEUROSCI.5115-09.2010","article-title":"Suppression of the intrinsic apoptosis pathway by synaptic activity","volume":"30","author":"L\u00e9veill\u00e9","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1450","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington\u2019s disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1455","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1460","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-B","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1465","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington\u2019s disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1470","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1523\/JNEUROSCI.0802-09.2009","article-title":"Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition","volume":"29","author":"Lau","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1475","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1480","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1073\/pnas.061020198","article-title":"Activation of Trk neurotrophin receptors in the absence of neurotrophins","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-12-801022-8.00010-6","article-title":"Adenosine receptors and Huntington\u2019s disease","volume":"119","author":"Lee","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0092-8674(02)00962-5","article-title":"Dual regulation of NMDA receptor functions by direct protein\u2013protein interactions with the dopamine D1 receptor","volume":"111","author":"Lee","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1495","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2006.08.035","article-title":"Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington\u2019s disease","volume":"1118","author":"Lee","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1500","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/sj.emboj.7601656","article-title":"Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1505","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1523\/JNEUROSCI.1990-04.2004","article-title":"Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats","volume":"24","author":"Lei","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1510","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jez.1401160206","article-title":"Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo","volume":"116","author":"Levi-Montalcini","year":"1951","journal-title":"J. Exp. Zool."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1515","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1520","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1525","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","article-title":"A huntingtin-associated protein enriched in brain with implications for pathology","volume":"378","author":"Li","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1530","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1535","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1540","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A<inf>2A<\/inf> receptors reverses working memory deficits at early stages of Huntington\u2019s disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1545","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1550","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1006\/mcne.2002.1152","article-title":"Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6\/2 Huntington\u2019s disease transgenic mice","volume":"20","author":"Li\u00e9vens","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1555","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1560","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jnr.20079","article-title":"Calcium modulates dopamine potentiation of N-methyl-D-aspartate responses: electrophysiological and imaging evidence","volume":"76","author":"Liu","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1565","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1570","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1152\/jn.1995.73.3.1076","article-title":"Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3","volume":"73","author":"Lovinger","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1575","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1740925X05000232","article-title":"Regulation of neurogenesis by neurotrophins: implications in hippocampus-dependent memory","volume":"1","author":"Lu","year":"2004","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1580","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"BDNF and synaptic plasticity, cognitive function, and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.pneurobio.2017.03.008_bib1585","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s100720200081","article-title":"Amantadine in Huntington\u2019s disease: open-label video-blinded study","volume":"23","author":"Lucetti","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1590","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1595","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1600","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington\u2019s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1605","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1610","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1523\/JNEUROSCI.5348-10.2011","article-title":"Region-specific involvement of BDNF secretion and synthesis in conditioned taste aversion memory formation","volume":"31","author":"Ma","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1615","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nbd.2015.08.008","article-title":"Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington\u2019s disease","volume":"82","author":"Ma","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1620","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1625","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/nbdi.2002.0528","article-title":"Pyramidal cell loss in motor cortices in Huntington\u2019s disease","volume":"10","author":"Macdonald","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1630","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2990.1997.tb01326.x","article-title":"Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington\u2019s disease","volume":"23","author":"Macdonald","year":"1997","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1635","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2016.04.001","article-title":"GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington\u2019s disease models","volume":"93","author":"Mahfooz","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1640","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1645","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","article-title":"Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis","volume":"11","author":"Mandolesi","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1650","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1655","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nm.3246","article-title":"Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington\u2019s disease models","volume":"19","author":"Marco","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1660","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nbd.2012.07.001","article-title":"The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation","volume":"48","author":"Mart\u00ednez-Turrillas","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1665","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-4522(91)90038-P","article-title":"Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease","volume":"42","author":"Martinez-Mir","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1670","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","article-title":"Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice","volume":"417","author":"Martire","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2009.09.012","article-title":"Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington\u2019s disease mice","volume":"37","author":"Martire","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1680","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jnc.12177","article-title":"BDNF prevents NMDA-induced toxicity in models of Huntington\u2019s disease: the effects are genotype specific and adenosine A2A receptor is involved","volume":"125","author":"Martire","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1685","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a005751","article-title":"Synapses and memory storage","volume":"4","author":"Mayford","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1695","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","article-title":"Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice","volume":"25","author":"Mazarakis","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1700","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00005053-196108000-00001","article-title":"The pathologic spectrum of Huntington\u2019s chorea","volume":"133","author":"McCaughey","year":"1961","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1705","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","article-title":"The organization of the projection from the cerebral cortex to the striatum in the rat","volume":"29","author":"McGeorge","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1710","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/6.5.775","article-title":"Reduced penetrance of the Huntington\u2019s disease mutation","volume":"6","author":"McNeil","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1715","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","article-title":"Glutamate as a neurotransmitter in the brain: review of physiology and pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1725","first-page":"CD006456","article-title":"Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease","author":"Mestre","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1730","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1523\/JNEUROSCI.5175-06.2007","article-title":"NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1","volume":"27","author":"Metzler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1735","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","article-title":"Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A","volume":"30","author":"Metzler","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1740","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nbd.2010.09.021","article-title":"A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington\u2019s disease","volume":"41","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1745","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1750","doi-asserted-by":"crossref","first-page":"53072","DOI":"10.1074\/jbc.M306230200","article-title":"Cysteine string protein (CSP) inhibition of N-type calcium channels is blocked by mutant huntingtin","volume":"278","author":"Miller","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1755","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1760","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0896-6273(00)80987-3","article-title":"Cognitive neuroscience and the study of memory","volume":"20","author":"Milner","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1765","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington\u2019s disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1770","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington\u2019s disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1775","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1780","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/nen.0b013e3180517477","article-title":"Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration","volume":"66","author":"Minghetti","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1785","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2738","article-title":"TrkB signalling pathways in LTP and learning","volume":"10","author":"Minichiello","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1790","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1795","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1523\/JNEUROSCI.20-18-07116.2000","article-title":"Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats","volume":"20","author":"Mizuno","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1800","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1805","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/hmg\/11.21.2547","article-title":"PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington\u2019s disease brains","volume":"11","author":"Modregger","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1810","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1471-4159.2001.00059.x","article-title":"Progressive depletion of complexin II in a transgenic mouse model of Huntington\u2019s disease","volume":"76","author":"Morton","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1815","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","article-title":"Abnormalities in the synaptic vesicle fusion machinery in Huntington\u2019s disease","volume":"56","author":"Morton","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1820","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","article-title":"Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington\u2019s disease","volume":"33","author":"Murmu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1825","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1830","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1073\/pnas.0807322106","article-title":"Control of extracellular cleavage of ProBDNF by high frequency neuronal activity","volume":"106","author":"Nagappan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1835","first-page":"3","article-title":"Afferent and efferent relationships of the basal ganglia","volume":"107","author":"Nauta","year":"1984","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1840","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1845","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neuron.2008.04.030","article-title":"Glutamate receptor dynamics in dendritic microdomains","volume":"58","author":"Newpher","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1850","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.0953-816X.2000.01379.x","article-title":"Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice","volume":"13","author":"Nicniocaill","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1855","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1523\/JNEUROSCI.16-07-02157.1996","article-title":"Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases","volume":"16","author":"Niethammer","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1860","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0896-6273(00)81009-0","article-title":"CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95\/SAP90","volume":"20","author":"Niethammer","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1865","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/jn.1992.67.2.477","article-title":"Presynaptic modulation by GABAB receptors of glutamatergic excitation and GABAergic inhibition of neostriatal neurons","volume":"67","author":"Nisenbaum","year":"1992","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1870","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1523\/JNEUROSCI.17-21-08147.1997","article-title":"Bidirectional regulation of DARPP-32 phosphorylation by dopamine","volume":"17","author":"Nishi","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1875","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.05.043","article-title":"Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington\u2019s disease","volume":"251","author":"Nithianantharajah","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1880","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1885","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/JGP.0b013e318196a632","article-title":"Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington\u2019s disease transgenic mice","volume":"17","author":"Nithianantharajah","year":"2009","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1890","first-page":"237","article-title":"BDNF function and intracellular signaling in neurons","volume":"25","author":"Numakawa","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1895","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1900","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00002826-200211000-00003","article-title":"Tetrabenazine treatment for Huntington\u2019s disease-associated chorea","volume":"25","author":"Ondo","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1905","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.parkreldis.2006.08.005","article-title":"A pilot study of the clinical efficacy and safety of memantine for Huntington\u2019s disease","volume":"13","author":"Ondo","year":"2007","journal-title":"Parkinsonism Related Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1910","doi-asserted-by":"crossref","first-page":"e16088","DOI":"10.1371\/journal.pone.0016088","article-title":"Striatal pre- and postsynaptic profile of adenosine a2a receptor antagonists","volume":"6","author":"Orr\u00fa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2011.08.005","article-title":"Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease","volume":"232","author":"Orr\u00fa","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1920","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jnnp.2009.171926","article-title":"Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease","volume":"81","author":"Orth","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1925","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06501.x","article-title":"Dysregulation of intracellular dopamine stores revealed in the R6\/2 mouse striatum","volume":"112","author":"Ortiz","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1930","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(01)00083-1","article-title":"Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats","volume":"41","author":"Ossowska","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1935","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nn1680","article-title":"Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1\/syndapin1","volume":"9","author":"P\u00e9rez-Ota\u00f1o","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1940","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1945","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","article-title":"Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington\u2019s disease transgenic mice","volume":"141","author":"Pang","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1950","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1955","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuropharm.2013.06.024","article-title":"BDNF mechanisms in late LTP formation: a synthesis and breakdown","volume":"76","author":"Panja","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1960","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1965","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1970","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1975","doi-asserted-by":"crossref","first-page":"11251","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1980","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0896-6273(00)80140-3","article-title":"Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice","volume":"16","author":"Patterson","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1985","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.2174\/092986711797535335","article-title":"Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging","volume":"18","author":"Paul","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1990","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine \u03b3-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib1995","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington\u2019s disease mice","volume":"11","author":"Peters\u00e9n","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2000","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1523\/JNEUROSCI.4255-14.2015","article-title":"Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes","volume":"35","author":"Petr","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2005","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/jm901689v","article-title":"Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)","volume":"53","author":"Pettersson","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2010.07.023","article-title":"In vivo pharmacology of the dopaminergic stabilizer pridopidine","volume":"644","author":"Ponten","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35049004","article-title":"Neurotrophins as synaptic modulators","volume":"2","author":"Poo","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2030","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(94)90715-3","article-title":"CGS 21680 antagonizes motor hyperactivity in a rat model of Huntington\u2019s disease","volume":"257","author":"Popoli","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00679-6","article-title":"Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats","volume":"287","author":"Popoli","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2040","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington\u2019s disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2050","series-title":"A Critical Evaluation of Adenosine A 2A Receptors as Potentially Druggable Targets in Huntington\u2019s Disease","first-page":"1500","author":"Popoli","year":"2008"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11302-007-9066-y","article-title":"Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington\u2019s disease","volume":"3","author":"Potenza","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2006.05.036","article-title":"Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors","volume":"404","author":"Pousinha","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2065","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1523\/JNEUROSCI.19-12-04972.1999","article-title":"Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice","volume":"19","author":"Pozzo-Miller","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2070","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1046\/j.1471-4159.1999.0732441.x","article-title":"D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors","volume":"73","author":"Price","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mds.26101","article-title":"A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington\u2019s disease","volume":"30","author":"Prundean","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuron.2005.08.016","article-title":"The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2","volume":"47","author":"Prybylowski","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2085","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","article-title":"A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease","volume":"24","author":"Puigdell\u00edvol","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2090","series-title":"Release of Transmitters from Synaptic Vesicles","author":"Purves","year":"2001"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington\u2019s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2100","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1523\/JNEUROSCI.0010-04.2004","article-title":"Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes","volume":"24","author":"Rajagopal","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2105","series-title":"Neuronal and Glial Somal Size in the Prefrontal Cortex: A Postmortem Morphometric Study of Schizophrenia and Huntington Disease","author":"Rajkowska","year":"1998"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2014.11.036","article-title":"Memantine exerts functional recovery by improving BDNF and GDNF expression in 3-nitropropionic acid intoxicated mice","volume":"586","author":"Ranju","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2115","first-page":"874387","article-title":"Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington\u2019s disease","volume":"2012","author":"Ransome","year":"2012","journal-title":"Neural Plas."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.25984","article-title":"Cerebellar abnormalities in Huntington\u2019s disease: a role in motor and psychiatric impairment?","volume":"29","author":"Rees","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2135","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cne.10541","article-title":"Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats","volume":"457","author":"Reiner","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2145","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/FBP.0b013e32833d41b2","article-title":"Using glutamate homeostasis as a target for treating addictive disorders","volume":"21","author":"Reissner","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2150","doi-asserted-by":"crossref","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington\u2019s disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199009063231013","article-title":"Brain GABA levels in asymptomatic Huntington\u2019s disease","volume":"323","author":"Reynolds","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1995.tb13303.x","article-title":"5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases","volume":"114","author":"Reynolds","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2165","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","article-title":"Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington\u2019s disease","volume":"30","author":"Ribeiro","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2170","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington\u2019s disease","volume":"23","author":"Ribeiro","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington\u2019s disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington\u2019s disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(81)90049-6","article-title":"Cerebellar atrophy in Huntington\u2019s disease","volume":"50","author":"Rodda","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1471-4159.2004.02887.x","article-title":"Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum","volume":"92","author":"Rodrigues","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0301-0082(98)00076-8","article-title":"Correlations between electrophysiological observations of synaptic plasticity modifications and behavioral performance in mammals","volume":"58","author":"Roman","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2200","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2015.10.039","article-title":"Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice","volume":"311","author":"Rothe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2210","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/mds.21601","article-title":"Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy","volume":"22","author":"Ruocco","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","article-title":"The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease","volume":"97","author":"Ryskamp","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0896-6273(00)00109-4","article-title":"The synaptic vesicle cycle revisited","volume":"28","author":"S\u00fcdhof","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cdd.2009.127","article-title":"pH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K\/Akt pro-survival pathway in Huntington\u2019s disease striatum","volume":"17","author":"Saavedra","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2230","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1523\/JNEUROSCI.3446-10.2011","article-title":"Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington\u2019s disease: a STEP in the resistance to excitotoxicity","volume":"31","author":"Saavedra","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2235","doi-asserted-by":"crossref","first-page":"e73664","DOI":"10.1371\/journal.pone.0073664","article-title":"Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington\u2019s disease","volume":"8","author":"Saavedra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2240","article-title":"BDNF induces striatal-enriched protein tyrosine phosphatase 61 degradation through the proteasome","volume":"1","author":"Saavedra","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/mp.2012.3","article-title":"The dopamine stabilizers ACR16 and (\u2212)-OSU6162 display nanomolar affinities at the \u03c3-1 receptor","volume":"18","author":"Sahlholm","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.410440117","article-title":"Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress","volume":"44","author":"Sawada","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2255","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/mds.870110612","article-title":"Evidence of cortical metabolic dysfunction in early Huntington\u2019s disease by single-photon-emission computed tomography","volume":"11","author":"Sax","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2260","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington\u2019s disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2270","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.biopsych.2008.12.026","article-title":"Abnormal motor cortex excitability in preclinical and very early Huntington&apos;s disease","volume":"65","author":"Schippling","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2280","doi-asserted-by":"crossref","first-page":"13902","DOI":"10.1073\/pnas.172511199","article-title":"Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number","volume":"99","author":"Schnell","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2285","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1523\/JNEUROSCI.1739-04.2004","article-title":"BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development","volume":"24","author":"Schratt","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2290","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/11208330-000000000-00000","article-title":"Tetrabenazine: for chorea associated with Huntington\u2019s disease","volume":"25","author":"Scott","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2295","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2300","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(88)92073-9","article-title":"Loss of matrix calcium-binding protein-containing neurons in Huntington\u2019s disease","volume":"331","author":"Seto-Ohshima","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2305","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.26331","article-title":"Therapeutic advances in huntington\u2019s disease","volume":"30","author":"Shannon","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2310","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000375447","article-title":"Overexpression of BDNF and full-length TrkB receptor ameliorate striatal neural survival in Huntington\u2019s disease","volume":"15","author":"Silva","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2320","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2325","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington\u2019s disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2330","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington\u2019s disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2335","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2340","first-page":"353","article-title":"Microcircuitry of the direct and indirect pathways of the basal ganglia","volume":"86","author":"Smith","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2345","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington\u2019s disease: a new perspective","volume":"62","author":"Smith","year":"2005","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2350","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nbd.2005.05.008","article-title":"Depletion of rabphilin 3A in a transgenic mouse model (R6\/1) of Huntington\u2019s disease, a possible culprit in synaptic dysfunction","volume":"20","author":"Smith","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2355","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington\u2019s disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.2007.04703.x","article-title":"Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington\u2019s disease","volume":"103","author":"Smith","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2365","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2370","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1523\/JNEUROSCI.18-24-10297.1998","article-title":"A dopamine\/D1 receptor\/protein kinase A\/dopamine- and cAMP-regulated phosphoprotein (Mr 32kDa)\/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor","volume":"18","author":"Snyder","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2375","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2380","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1212\/WNL.43.10.2088","article-title":"Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington\u2019s disease: a quantitative Golgi study","volume":"43","author":"Sotrel","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2385","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2390","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","article-title":"Neuronal loss in the hippocampus in Huntington\u2019s disease: a comparison with HIV infection","volume":"56","author":"Spargo","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2395","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0169-328X(02)00216-4","article-title":"Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington\u2019s disease","volume":"102","author":"Spektor","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2400","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2405","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2415","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-009-1103-3","article-title":"Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins","volume":"36","author":"Squitieri","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2420","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/jcmm.12604","article-title":"Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6\/2 mouse model","volume":"19","author":"Squitieri","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0169-328X(98)00293-9","article-title":"Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat","volume":"64","author":"Standaert","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2430","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington\u2019s disease","volume":"82","author":"Starling","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnsys.2011.00047","article-title":"Functional changes in neocortical activity in Huntington\u2019s disease model mice: an in vivo intracellular study","volume":"5","author":"Stern","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2440","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(93)90073-Q","article-title":"Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington\u2019s disease","volume":"242","author":"Steward","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2445","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington\u2019s disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2450","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-004-1795-9","article-title":"Hippocampal function in cognition","volume":"174","author":"Sweatt","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2460","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.1152864","article-title":"Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines","volume":"319","author":"Tanaka","year":"2008","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2465","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2470","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Tang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2475","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2480","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jnr.20138","article-title":"Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum","volume":"77","author":"Tebano","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2485","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11302-006-9026-y","article-title":"Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus","volume":"2","author":"Tebano","year":"2006","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2490","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2007.05046.x","article-title":"Adenosine A2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus","volume":"104","author":"Tebano","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2495","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tins.2004.08.007","article-title":"GABAergic microcircuits in the neostriatum","volume":"27","author":"Tepper","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2500","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresrev.2007.10.008","article-title":"Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons","volume":"58","author":"Tepper","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2505","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2510","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/brain\/111.2.223","article-title":"The coexistence of bradykinesia and chorea in Huntington\u2019s disease and its implications for theories of basal ganglia control of movement","volume":"111","author":"Thompson","year":"1988","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2515","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0021-9258(19)88378-3","article-title":"Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element","volume":"274","author":"Timmusk","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2520","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1074\/jbc.272.8.5157","article-title":"Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies","volume":"272","author":"Tingley","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2525","doi-asserted-by":"crossref","first-page":"e87923","DOI":"10.1371\/journal.pone.0087923","article-title":"A monoclonal antibody TrkB receptor agonist as a potential therapeutic for huntington\u2019s disease","volume":"9","author":"Todd","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2530","first-page":"81","article-title":"Tetrabenazine in the treatment of Huntington\u2019s chorea and other hyperkinetic movement disorders","volume":"39","author":"Toglia","year":"1978","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2535","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","article-title":"Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling","volume":"29","author":"Torres-Peraza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2540","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2545","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2550","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2014.11.004","article-title":"Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington\u2019s disease","volume":"74","author":"Tyebji","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2560","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1523\/JNEUROSCI.21-12-04249.2001","article-title":"BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses","volume":"21","author":"Tyler","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2565","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1523\/JNEUROSCI.08-12-04755.1988","article-title":"Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents","volume":"8","author":"Uhl","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2570","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2005.03378.x","article-title":"Spatio-temporal activation of cyclic AMP response element-binding protein, activity-regulated cytoskeletal-associated protein and brain-derived nerve growth factor: a mechanism for pontine-wave generator activation-dependent two-way active-avoidance memor","volume":"95","author":"Ulloor","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2575","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer A\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2580","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2585","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2590","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0959-4388(03)00073-4","article-title":"Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation","volume":"13","author":"Vanhoutte","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2595","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2600","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2605","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2610","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/WNL.59.5.694","article-title":"Huntington\u2019s disease: a randomized, controlled trial using the NMDA-antagonist amantadine","volume":"59","author":"Verhagen Metman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2615","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1460-9568.1991.tb00036.x","article-title":"Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor","volume":"3","author":"Vezina","year":"1991","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2620","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","article-title":"Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease","volume":"15","author":"Villar-Menendez","year":"2013","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2625","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2635","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-4522(89)90082-1","article-title":"Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington\u2019s chorea but not in Parkinson\u2019s disease: a quantitative in vitro autoradiography study","volume":"32","author":"Waeber","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2640","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/exnr.1994.1081","article-title":"Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington\u2019s disease","volume":"127","author":"Wagster","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2645","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-5434-2_9","article-title":"Selective neurodegeneration, neuropathology and symptom profiles in Huntington\u2019s disease","volume":"769","author":"Waldvogel","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2650","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2655","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroscience.2016.02.069","article-title":"The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175WT\/HD mice","volume":"324","author":"Wehner","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2660","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2665","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2670","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410180207","article-title":"Neurotransmitter receptor alterations in Huntington\u2019s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes","volume":"18","author":"Whitehouse","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2675","doi-asserted-by":"crossref","first-page":"17210","DOI":"10.1073\/pnas.0705267104","article-title":"Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB","volume":"104","author":"Wiese","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2680","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington\u2019s disease: what\u2019s in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2685","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hbm.20502","article-title":"Cortical dysfunction in patients with Huntington\u00f6s disease during working memory performance","volume":"30","author":"Wolf","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2690","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JHD-140114","article-title":"Presymptomatic glutamate levels in prefrontal cortex in the Hdh(CAG150) mouse model of Huntington\u2019s disease","volume":"3","author":"Wolfram-Aduan","year":"2014","journal-title":"J. Huntington. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2013.00019","article-title":"Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses","volume":"6","author":"Won","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2700","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-4328(96)00106-4","article-title":"Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders","volume":"73","author":"Wong","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2705","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2710","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington\u2019s disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2715","first-page":"2923","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease","volume":"25","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2720","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1074\/jbc.M109.073197","article-title":"Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2725","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2730","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","article-title":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington\u2019s disease: role in excitotoxicity","volume":"36","author":"Xifro","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2735","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2212-09.2009","article-title":"Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP","volume":"29","author":"Xu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2740","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1083\/jcb.201303146","article-title":"Synaptic mutant huntingtin inhibits synapsin-1 phosphorylation and causes neurological symptoms","volume":"202","author":"Xu","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2745","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington\u2019s disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2750","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1471-4159.2002.01084.x","article-title":"Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington\u2019s disease","volume":"82","author":"Yohrling","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2755","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington\u2019s disease","volume":"241","author":"Young","year":"1988","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2760","doi-asserted-by":"crossref","first-page":"e75108","DOI":"10.1371\/journal.pone.0075108","article-title":"Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice","volume":"8","author":"Young","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2765","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2770","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington\u2019s disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2775","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","article-title":"Depletion of wild-type huntingtin in mouse models of neurologic diseases","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2780","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-4159.2004.02350.x","article-title":"Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival","volume":"89","author":"Zheng","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2785","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington\u2019s disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2790","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington\u2019s disease","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2795","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2800","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2805","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2810","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2815","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pneurobio.2017.03.008_bib2820","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington\u2019s disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T20:18:20Z","timestamp":1750191500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008216300892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":564,"alternative-id":["S0301008216300892"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2017.03.008","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}